Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Universidade de São Paulo](/img/noimage_org.png)
Universidade de São Paulo
São Paulo, BrasilPublications in collaboration with researchers from Universidade de São Paulo (6)
2018
-
GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice
International Journal of Obesity, Vol. 42, Núm. 5, pp. 1062-1072
2017
-
TFOS DEWS II Management and Therapy Report
Ocular Surface, Vol. 15, Núm. 3, pp. 575-628
2016
-
New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr
-/-
mice
Pharmacological Research, Vol. 104, pp. 49-60
2015
-
New indole-thiazolidine attenuates atherosclerosis in LDLr-/- mice
Vascular Pharmacology, Vol. 71, pp. 174-180
2010
-
Electronegative LDL induction of apoptosis in macrophages: Involvement of Nrf2
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1801, Núm. 4, pp. 430-437
2009
-
Clinicians Agreement in Establishing Glaucomatous Progression Using the Heidelberg Retina Tomograph
Ophthalmology, Vol. 116, Núm. 1, pp. 14-24